{"id":"lovenox-enoxaparin","safety":{"commonSideEffects":[{"rate":"1-3","effect":"Bleeding"},{"rate":"0.1-1","effect":"Thrombocytopenia"},{"rate":"5-10","effect":"Injection site hematoma"},{"rate":"1-3","effect":"Elevated liver enzymes"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Enoxaparin binds to and potentiates antithrombin III, a natural anticoagulant, leading to inactivation of coagulation factors Xa and IIa. This prevents thrombin generation and fibrin clot formation. It is administered subcutaneously and has more predictable pharmacokinetics than unfractionated heparin.","oneSentence":"Enoxaparin is a low-molecular-weight heparin that inhibits blood clotting by enhancing the activity of antithrombin III against factors Xa and IIa.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:19:28.166Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip or knee replacement surgery"},{"name":"Prophylaxis of DVT in patients with acute illness"},{"name":"Treatment of acute DVT and pulmonary embolism"},{"name":"Acute coronary syndrome (unstable angina and non-ST-segment elevation myocardial infarction)"}]},"trialDetails":[{"nctId":"NCT07124819","phase":"PHASE3","title":"Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin","status":"COMPLETED","sponsor":"Avexima Diol LLC","startDate":"2024-07-22","conditions":"Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Venous Thromboembolism (VTE)","enrollment":215},{"nctId":"NCT05293132","phase":"PHASE2, PHASE3","title":"Effect of Montelukast Versus Co Enzyme in Sepsis","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-02-01","conditions":"Sepsis","enrollment":90},{"nctId":"NCT02474212","phase":"PHASE4","title":": Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery","status":"COMPLETED","sponsor":"Tampere University Hospital","startDate":"2016-05","conditions":"Venous Thromboembolism, Pulmonary Embolism, Thromboprophylaxis","enrollment":85},{"nctId":"NCT05417997","phase":"PHASE3","title":"Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients","status":"COMPLETED","sponsor":"RAAS Nutritionals, LLC","startDate":"2021-05-29","conditions":"COVID-19 Respiratory Infection, FLU, Cold; Influenza","enrollment":71},{"nctId":"NCT04400799","phase":"PHASE3","title":"Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19","status":"TERMINATED","sponsor":"University of Zurich","startDate":"2020-06-15","conditions":"COVID-19, Pulmonary Embolism, Deep Vein Thrombosis","enrollment":475},{"nctId":"NCT05265676","phase":"PHASE1","title":"Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects","status":"COMPLETED","sponsor":"Venus Remedies Limited","startDate":"2021-02-26","conditions":"Healthy","enrollment":24},{"nctId":"NCT05237843","phase":"PHASE1","title":"Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2022-03-01","conditions":"Recurrent Pregnancy Loss","enrollment":70},{"nctId":"NCT02444572","phase":"PHASE4","title":"Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox®","status":"COMPLETED","sponsor":"Les Laboratoires des Médicaments Stériles","startDate":"2015-10","conditions":"Gastrointestinal Neoplasms, Thromboembolic Event","enrollment":168},{"nctId":"NCT02081950","phase":"PHASE1","title":"A Single-Dose Trial to Examine the Within Subject Variability of Clexane® in Healthy Adults Under Fasting Conditions","status":"COMPLETED","sponsor":"Chemi S.p.A.","startDate":"2014-03","conditions":"Clexane is Administered to Healthy Volunteers","enrollment":14},{"nctId":"NCT02232802","phase":"PHASE1","title":"Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.","status":"COMPLETED","sponsor":"Chemi S.p.A.","startDate":"2014-08-04","conditions":"Enoxaparin Sodium is Administered to Healthy Volunteers","enrollment":47},{"nctId":"NCT00633061","phase":"PHASE2","title":"Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2008-06","conditions":"Childhood Cancer, Central Venous Catheters, Deep Vein Thrombosis","enrollment":136},{"nctId":"NCT04408235","phase":"PHASE3","title":"High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy","status":"UNKNOWN","sponsor":"Azienda Ospedaliero-Universitaria di Modena","startDate":"2020-06","conditions":"COVID, Pneumonia, Viral, Coagulation Disorder","enrollment":300},{"nctId":"NCT04402762","phase":"PHASE1, PHASE2","title":"Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2019-12-20","conditions":"Enoxaparin","enrollment":20},{"nctId":"NCT04344756","phase":"PHASE2","title":"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04-20","conditions":"COVID19 Pneumonia","enrollment":808},{"nctId":"NCT04235569","phase":"PHASE4","title":"Warfarin Initiation in Mechanical Mitral Valve Replacement Patients","status":"COMPLETED","sponsor":"Sarah Sabry Hashem","startDate":"2018-03-01","conditions":"Mitral Valve Disease","enrollment":50},{"nctId":"NCT02744833","phase":"PHASE1, PHASE2","title":"Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)","status":"TERMINATED","sponsor":"GlycoMimetics Incorporated","startDate":"2016-07","conditions":"Deep Venous Thrombosis","enrollment":2},{"nctId":"NCT00894283","phase":"EARLY_PHASE1","title":"Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2009-06","conditions":"Deep Venous Thrombosis, Pulmonary Embolism","enrollment":198},{"nctId":"NCT01817257","phase":"PHASE2","title":"Anticoagulation Length in Cancer Associated Thrombosis","status":"TERMINATED","sponsor":"Cardiff University","startDate":"2013-12","conditions":"Cancer, Thrombosis, Venous Thromboembolism","enrollment":2},{"nctId":"NCT02271113","phase":"PHASE1","title":"Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects","status":"COMPLETED","sponsor":"GlycoMimetics Incorporated","startDate":"2014-10","conditions":"Healthy Volunteers","enrollment":32},{"nctId":"NCT02271295","phase":"PHASE3","title":"Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients","status":"SUSPENDED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-07-27","conditions":"Cirrhosis","enrollment":16},{"nctId":"NCT03363477","phase":"PHASE1","title":"Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy Volunteers","status":"COMPLETED","sponsor":"Rovi Pharmaceuticals Laboratories","startDate":"2015-09-25","conditions":"Healthy","enrollment":46},{"nctId":"NCT01444612","phase":"","title":"Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-02","conditions":"Thrombosis, Venous","enrollment":4068},{"nctId":"NCT03088358","phase":"PHASE2","title":"Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement","status":"COMPLETED","sponsor":"TeaRx LLC","startDate":"2013-08","conditions":"Total Knee Replacement","enrollment":200},{"nctId":"NCT02368314","phase":"PHASE3","title":"A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries","status":"COMPLETED","sponsor":"Biocad","startDate":"2015-01","conditions":"Deep Vein Thrombosis","enrollment":124},{"nctId":"NCT02865174","phase":"PHASE4","title":"Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2016-09","conditions":"Osteoarthritis, Knee","enrollment":90},{"nctId":"NCT00836355","phase":"NA","title":"Enoxaparin and/or Minocycline in Acute Stroke","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2009-04","conditions":"Acute Ischemic Stroke","enrollment":6},{"nctId":"NCT02325479","phase":"PHASE1","title":"Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI)","status":"COMPLETED","sponsor":"The Egyptian IVF-ET Center","startDate":"2015-01","conditions":"Infertility","enrollment":120},{"nctId":"NCT00986765","phase":"PHASE3","title":"Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-06","conditions":"Preeclampsia","enrollment":257},{"nctId":"NCT00371683","phase":"PHASE3","title":"Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2006-11","conditions":"Deep Vein Thrombosis, Pulmonary Embolism","enrollment":3608},{"nctId":"NCT01687491","phase":"PHASE4","title":"Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Les Laboratoires des Médicaments Stériles","startDate":"2012-07","conditions":"Acute Coronary Syndrome, Factor X","enrollment":179},{"nctId":"NCT00111748","phase":"PHASE3","title":"UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2005-02","conditions":"Multiple Myeloma","enrollment":180},{"nctId":"NCT01356992","phase":"PHASE3","title":"Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation","status":"TERMINATED","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2012-07","conditions":"Non ST Segment Elevation Myocardial Infarction, Unstable Angina","enrollment":62},{"nctId":"NCT00452530","phase":"PHASE3","title":"Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2007-06","conditions":"Deep Vein Thrombosis, Pulmonary Embolism","enrollment":3221},{"nctId":"NCT00423319","phase":"PHASE3","title":"Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2007-03","conditions":"Deep Vein Thrombosis, Pulmonary Embolism","enrollment":5407},{"nctId":"NCT00679588","phase":"PHASE3","title":"Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-04","conditions":"Venous Thromboembolism","enrollment":4413},{"nctId":"NCT00721760","phase":"PHASE3","title":"Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-07","conditions":"Venous Thromboembolism","enrollment":1003},{"nctId":"NCT00697099","phase":"PHASE3","title":"Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-06","conditions":"Venous Thromboembolism","enrollment":2326},{"nctId":"NCT00718224","phase":"PHASE3","title":"Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-07","conditions":"Venous Thromboembolism","enrollment":1150},{"nctId":"NCT00714597","phase":"PHASE3","title":"Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility","status":"TERMINATED","sponsor":"Sanofi","startDate":"2008-07","conditions":"Venous Thromboembolism","enrollment":421},{"nctId":"NCT00331838","phase":"PHASE2","title":"Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-05","conditions":"Venous Thromboembolism","enrollment":705}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6035,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Lovenox® (enoxaparin)","genericName":"Lovenox® (enoxaparin)","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Enoxaparin is a low-molecular-weight heparin that inhibits blood clotting by enhancing the activity of antithrombin III against factors Xa and IIa. Used for Prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip or knee replacement surgery, Prophylaxis of DVT in patients with acute illness, Treatment of acute DVT and pulmonary embolism.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}